Park Ha Biological Technology is trading at $2.25 (-6.64%) with no verified September 21 company announcement, earnings release, or major filing directly explaining the decline.
- It closed at $2.41 on September 18, 2026.
- Recent coverage concerns a securities-class-action lead-plaintiff deadline, but it is not confirmed as the catalyst.
- Broader markets are higher, so the move does not appear aligned with market direction.